Table · dataset · 2026
Data set for Kamau et al. Evaluation of VITEK® REVEAL<sup>TM</sup> Fast AST System vs. VITEK® 2 for Antimicrobial Susceptibility Testing of Gram-negative Bacteria from Positive Blood Cultures
Listed in figshare
<p dir="ltr">This study compared the VITEK® REVEAL<sup>TM</sup> fast AST system for direct testing from positive blood cultures (PBCs) with the standard-of-care VITEK® 2.A total of 250 prospectively collected PBC bottles containing monomicrobial Gram-negative organisms were assessed.
Description
AST was performed using VITEK® REVEAL<sup>TM</sup> directly from PBC and VITEK® 2 from isolated colonies recovered from the PBC. Essential agreement (EA), categorical agreement (CA), and discrepancy rates were calculated.
Time to result (TTR) was also recorded. When compared to VITEK® 2, VITEK® REVEAL<sup>TM</sup> demonstrated EA of 97.51% and CA of 94.83% across 4,180 organism–antimicrobial comparisons with agreement exceeding 95% for most antimicrobials. When evaluating instrument run time (not inclusive of the 18-24 h subculture times), the REVEAL<sup>TM</sup> reported final results approximately 4 hours sooner than VITEK® 2 (median 8.0 h vs 11.9 h).
Read the rest (1 more)
REVEAL<sup>TM</sup> reported final results for resistant isolates faster than susceptible or intermediate isolates (median 5.4 h vs 6.5 h). VITEK® REVEAL<sup>TM</sup> provides fast, accurate phenotypic AST directly from positive blood cultures comprising monomicrobial Gram-negative organisms and complements VITEK® 2 by accelerating early susceptibility reporting.</p>
Links
Where it is published
- DOI doi.org/10.6084/m9.figshare.33819883.v1 ↗
DOI / persistent id · from figshare com
Catalogue records · 1
- OAI-PMH record api.figshare.com/v2/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Af… ↗
metadata API · from figshare com
Topics
Provenance · 1 source records, 17 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| figshare | oai:figshare.com:article/33819883 | 4 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].anzsrc:field:320701 | mapping · figshare com | vocabulary-mapper@1.0.0 | keywords['Medical bacteriology'] |
| concepts[field].local:field:astronomy | mapping · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].local:field:chemistry | mapping · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].local:field:computer-science-ai | mapping · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].local:field:earth-environmental | mapping · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].local:field:economics-finance | mapping · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].local:field:engineering | mapping · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].local:field:humanities | mapping · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].local:field:life-sciences | mapping · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].local:field:medicine-health | mapping · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].local:field:ocean-atmospheric | mapping · figshare com | connector:figshare_com@1.0.0 | |
| concepts[field].local:field:social-science | mapping · figshare com | connector:figshare_com@1.0.0 | |
| description | source · figshare com | connector:figshare_com@1.0.0 | /metadata/dc/description |
| license | source · figshare com | connector:figshare_com@1.0.0 | /metadata/dc/rights |
| publication_date | source · figshare com | connector:figshare_com@1.0.0 | |
| title | source · figshare com | connector:figshare_com@1.0.0 | /metadata/dc/title |